Optimism at Boots
Article Abstract:
Boots shares have been affected by publicity over speculation that retail price maintenance may end for some non-prescription drugs. A sample of six brokers was asked about prospects for the company's shares, and four of the six rate the shares a buy. BZW argues that changes affecting drug pricing are not likely to have much impact. Williams de Broe notes that Boots has increased its market share, and this broker is also a buyer. Panmure Gordon is among brokers rating the shares a hold.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Rooting for Boots
Article Abstract:
The share price of Boots is affected by parts of the group which have not performed well such as Fads, but the core drugstore business is performing well. Four brokers of a sample of six rate Boots shares a buy, while two brokers are holders. Buyers include Williams de Broe, UBS, and Mees Pierson. Holders include Societe General Strauss Turnbull which is concerned about the impact on short term earnings of an investment in over-the-counter drugs.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Fill your Boots
Article Abstract:
Boots' performance has been boosted by Boots The Chemists, but other activities have had a mixed performance. Four brokers from a sample of six rate the company's stocks a buy, one rates them a hold and one rates them a sell. The buyers are NatWest Securities, BZW, HSBC James Capel and Sutherlands. Williams de Broe is the holder, and the seller is Panmure Gordon which sees the stock price as reflecting the company's strong position.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Telecoms: BT coup for Generale boss. Waiting for BT to spend. Dial BT for value
- Abstracts: Lateral thinking. Moving on, losing out. Home income plans
- Abstracts: Chunnel may transform Kent's fortunes. Room for a little one. All change at the top
- Abstracts: NatWest's $4bn poser. NatWest in favour. Solid story at Lloyds
- Abstracts: Pension mis-selling: costly top-ups. Look out for the great disapperaing act. Bogged down